Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Connected ! Smart people often find each other !
View:
Post by CrazyProphet on May 03, 2021 5:58pm

Connected ! Smart people often find each other !

Vaxart getting good press today on their Covid oral vaccine ! The dude who owns the Mfg signed on to make the vaccine pill Attwill medical also sits on the Revive board and Attwill is involved in our trials !

Revive Therapeutics (CSE: RVV) (OTC: RVVTF) is one step closer to conducting its phase 3 clinical trials for the use of Bucillamine in the treatment of COVID-19. The company announced this morning that it has signed a memorandum of understanding with Attwill Medical Solutions Sterilflow, LP to establish the firm as a resource for clinical packaging and distribution for Revive’s clinical trials. Notably, Attwill recently signed on as the large scale manufacturer and a resource for lyophilization development for that of Vaxart Inc’s (NASDAQ: VXRT) COVID-19 vaccine.

Attwill Medical Solutions, based in Wisconsin, is one of the largest facilities in the US that specializes in lyophilization services.

Comment by TheTerminator1 on May 03, 2021 7:28pm
How sweet it is
Comment by 1ottrunner on May 03, 2021 7:41pm
The good press Vaxart is getting is not RVV, it is the competition.
Comment by cool888 on May 03, 2021 7:51pm
Another Great post (negative) !! Keep it up !! am sure another one in the very early morning, as usual to start a Great Day !!
Comment by 1ottrunner on May 03, 2021 8:18pm
I'm simply trying to introduce a bit of reality here. FYI->  The success rate of a phase 3 trial is just under half, yet those have had to stand the muster of phase 1/2. If MF knows the trial results he MUST tell the investors.  He is LEGALLY obligated to do so within a reasonable amount of time.  Cool I understand your position, you are very hopeful.  I'm simply ...more  
Comment by cool888 on May 03, 2021 8:56pm
Thanks for the response. I am STILL  100 % very posiive and  hope for the BEST GLTA !!
Comment by TheTerminator1 on May 03, 2021 8:18pm
Vaxart will be manufacturing RVV's Bucillamine in the Pill form